The epidemiology of anaphylaxis in Europe: A systematic review

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 11, 2013, Pages 1353-1361

  Panesar, S S ^a   Javad, S ^b   De Silva, D ^c   Nwaru, B I ^d   Hickstein, L ^e   Muraro, A ^f   Roberts, G ^g,h   Worm, M ^i,j   Bilo M B ^k   Cardona, V ^l   Dubois, A E J ^m   Dunn Galvin, A ⁿ   Eigenmann, P ^o   Fernandez Rivas, M ^p   Halken, S ^q   Lack, G ^r   Niggemann, B ^j   Santos, A F ^r,s,t   Vlieg Boerstra, B J ^u,v   Zolkipli, Z Q ^h   Sheikh, A ^a,v   more..

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Evidence Centre   (United Kingdom)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF PADOVA   (Italy)

^g ST MARY S HOSPITAL   (United Kingdom)

^h UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

ⁱ UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k OSPEDALI RIUNITI   (Italy)

^l HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^m UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁿ UNIVERSITY COLLEGE CORK   (Ireland)

^o GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^p HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^q ODENSE UNIVERSITY HOSPITAL   (Denmark)

^r KING'S COLLEGE LONDON   (United Kingdom)

^s KING'S COLLEGE LONDON   (United Kingdom)

^t CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^u ACADEMIC MEDICAL CENTER   (Netherlands)

^v BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

anaphylaxis; epidemiology; incidence; prevalence; risk factors

Indexed keywords

ACETYLSALICYLIC ACID; AMPICILLIN; CEPHALOSPORIN DERIVATIVE; CLOXACILLIN; CONTRAST MEDIUM; DEXTRAN; DICLOFENAC; DIPYRONE; FOOD ALLERGEN; LATEX; PARACETAMOL; PENTOXIFYLLINE; STREPTOKINASE;

ALLERGIC RHINITIS; ANAPHYLAXIS; ASTHMA; ATOPIC DERMATITIS; COMORBIDITY; CROSS REACTION; DRUG HYPERSENSITIVITY; EGG; EMERGENCY CARE; EUROPE; FATALITY; FISH; FOOD ALLERGY; HAY FEVER; HAZELNUT; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INSECT STING; META ANALYSIS (TOPIC); MILK; NUT; PEANUT; PERENNIAL RHINITIS; PINE; PLASMA; POLLEN; POLLEN ALLERGY; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SHRIMP; SYSTEMATIC REVIEW; TIME; WALNUT; WHEAT;

ANAPHYLAXIS; EPIDEMIOLOGY; INCIDENCE; PREVALENCE; RISK FACTORS;

ANAPHYLAXIS; ANIMALS; EUROPE; HUMANS; INCIDENCE; PREVALENCE; RISK FACTORS; SYNDROME; TIME FACTORS;

EID: 84887476610     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12272     Document Type: Review

References (73)

1. American Academy of Pediatrics. Committee on School Health. Guidelines for urgent care in school. Pediatrics 1990; 86: 999-1000.
2. International Collaborative Study of Severe Anaphylaxis. An epidemiologic study of severe anaphylactic and anaphylactoid reactions among hospital patients: methods and overall risks. Epidemiology 1998; 9: 141-146.
3. Australasian Society of Clinical Immunology and Allergy Inc. (ASCIA). Guidelines for EpiPen prescription. ASCIA Anaphylaxis Working Party 2004. Available online at http://www.allergy.org.au/anaphylaxis/epipen-guidelines.htm. Last accessed 20 September 2012.
4. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; and Joint Council of Allergy, Asthma, and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 2005; 115 (3 suppl): S483-S523.
5. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF, Bock A, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391-397.
6. Lieberman P, Camargo CA, Bohlke K, Jick H, Miller RL, Sheikh A, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 2006; 97: 596-602.
7. Simons FE, Sheikh A,. Evidence-based management of anaphylaxis. Allergy 2007; 62: 827-829.
8. Last JM, editor. A dictionary of epidemiology. 4th ed. New York, NY: Oxford University Press, 2000.
9. Simons FE, Sheikh A,. Anaphylaxis: the acute episode and beyond. BMJ 2013; 346: f602.
10. Panesar SS, Nwaru BI, Hickstein L, Rader T, Hamadah H, Ali DF, et al., European Academy of Allergy and Clinical Immunology Food Allergy and Anaphylaxis Guidelines group. The epidemiology of anaphylaxis in Europe: protocol for a systematic review. Clin Transl Allergy 2013; 3: 9.
11. OCEBM Levels of Evidence Working Group. 'The Oxford 2011 Levels of Evidence'. Oxford Centre for Evidence-Based Medicine. Available online at http://www.cebm.net/index.aspx?o = 5653. Last accessed 28 September 2012.
12. CASP checklist for systematic reviews. http://www.casp-uk.net/wp-content/ uploads/2011/11/CASP-Systematic-Review-Appraisal-Checklist-14oct10.pdf. Last accessed 10 October 2012.
13. CASP checklist for cohort studies. http://www.casp-uk.net/wp-content/ uploads/2011/11/CASP-Cohort-Appraisal-Checklist-14oct10.pdf. Last accessed 10 October 2012.
14. CASP checklist for case-control studies. http://www.casp-uk.net/wp- content/uploads/2011/11/CASP-Case-Control-Appraisal-Checklist-14oct10.pdf. Last accessed 10 October 2012.
15. Appraisal Tools http://www.phru.nhs.uk/Pages/PHD/resources.htm. Last accessed 20 September 2012.
16. Effective Public Health Practice Project Quality Assessment Tool. http://www.ephpp.ca/PDF/Quality%20Assessment%20Tool-2010-2.pdf. Last accessed 10 October 2012.
17. Agresti A, Coull BA,. Approximate is better than 'exact' for interval estimation of binomial proportions. Am Statis 1998; 52: 119-126.
18. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement. PLoS Med 6: e1000097.
19. Alvarado MI, Perez M,. Study of food allergy in the Spanish population. Allergol Immunopathol 2006; 34: 185-193.
20. Asero R, Antonicelli L, Arena A, Bommarito L, Caruso B, Colombo G, et al. Causes of food-induced anaphylaxis in Italian adults: a multi-centre study. Int Arch Allergy Immunol 2009; 150: 271-277.
21. Borch JE, Andersen KE, Bindslev-Jensen C,. The prevalence of suspected and challenge-verified penicillin allergy in a university hospital population. Basic Clin Pharmacol Toxicol 2006; 98: 357-362.
22. Bousquet PJ, Kvedariene V, Co-Minh HB, Martins P, Rongier M, Arnoux B, et al. Clinical presentation and time course in hypersensitivity reactions to beta-lactams. Allergy 2007; 62: 872-876.
23. Calvani M, Di Lallo D, Polo A, Spinelli A, Zappala D, Zicari AM,. Hospitalizations for pediatric anaphylaxis. Int J Immunopathol Pharmacol 2008; 21: 977-983.
24. Calvani M, Cardinale F, Martelli A, Muraro A, Pucci N, Savino F, et al. Risk factors for severe pediatric food anaphylaxis in Italy. Pediatr Allergy Immunol 2011; 22: 813-819.
25. Capps JA, Sharma V, Arkwright PD,. Prevalence, outcome and pre-hospital management of anaphylaxis by first aiders and paramedical ambulance staff in Manchester. UK. Resuscitation 2010; 81: 653-657.
26. Celikel S, Karakaya G, Yurtsever N, Sorkun K, Kalyoncu AF,. Bee and bee products allergy in Turkish beekeepers: Determination of risk factors for systemic reactions. Allergologia et Immunopathol, 2006; 34: 180-184.
27. Derby CJ, Gowland MH, Hourihane JO,. Sesame allergy in Britain: a questionnaire survey of members of the anaphylaxis campaign. Pediatr Allergy Immunol 2005; 16: 171-175.
28. Draisci G, Zanfini BA, Nucera E, Catarci S, Sangregorio R, Schiavino D, et al. Latex sensitization: a special risk for the obstetric population? Anesthesiology 2011; 114: 565-569.
29. Gonzalez-Perez A, Aponte Z, Vidaurre CF, Rodriguez LAG,. Anaphylaxis epidemiology in patients with and patients without asthma: a united kingdom database review. J Allergy Clin Immunol 2010; 125: 1098-1104.
30. Helbling A, Hurni T, Mueller UR, Pichler WJ,. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940 000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004; 34: 285-290.
31. Kanny G, Moneret-Vautrin DA, Flabbee J, Beaudouin E, Morisset M, Thevenin F,. Population study of food allergy in France. J Allergy Clin Immunol 2001; 108: 133-140.
32. Lange L, Koningsbruggen SV, Rietschel E,. Questionnaire-based survey of lifetime-prevalence and character of allergic drug reactions in German children. Pediatr Allergy Immunol 2008; 19: 634-638.
33. Laporte JR, de Latorre FJ, Laszlo A, Retsagi G, Gadgil DA, Chandrasekhar DV, et al. Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf 2003; 12: 195-202. (International Collaborative Study of Severe Anaphylaxis)
34. Laxenaire MC, Mertes PM,. Groupe d'Etudes des Reactions Anaphylactoides, Peranesthesiques. Anaphylaxis during anaesthesia. results of a two-year survey in France. Br J Anaesth 2001; 87: 549-558.
35. Nybo M, Madsen JS,. Serious anaphylactic reactions due to protamine sulfate: a systematic literature review. Basic Clin Pharmacol Toxicol 2008; 103: 192-196.
36. Pastorello EA, Rivolta F, Bianchi M, Mauro M, Pravettoni V,. Incidence of anaphylaxis in the emergency department of a general hospital in Milan. J Chromatogr B Biomed Sci Appl 2001; 756: 11-17.
37. Perez Pimiento AJ, Prieto Lastra L, Rodriguez Cabreros MI, Vasquez Bautista AA, Garcia Cubero A, Calvo Manue lE,. Systemic reactions to wasp sting: is the clinical pattern related to age, sex and atopy?. [erratum appears in allergol immunopathol (madr). 2007 mar-apr;35(2):51]. Allergol Immunopathol 2007; 35: 10-14.
38. Quercia O, Incorvaia C, Puccinelli P, Scurati S, Emiliani F, Frati F, et al. Prevalence of allergic disorders in Italy: the Cotignola population study. Eur Ann Allergy & ClinImmunol 2012; 44: 5-11.
39. Quiralte J, Blanco C, Delgado J, Ortega N, Alcntara M, Castillo R, et al. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions. J Investig Allergol Clin Immunol 2007; 17: 182-188.
40. Rance F, Grandmottet X, Grandjean H,. Prevalence and main characteristics of schoolchildren diagnosed with food allergies in France. Clin Exp Allergy 2005; 35: 167-172.
41. Rasmussen TA, Jorgensen MRS, Bjerrum S, Jensen-Fangel S, Stovring H, Ostergaard L, et al. Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study. BMJ 2012; 345: e5823.
42. Sandilands EA, Bateman DN,. Adverse reactions associated with acetylcysteine. CliniToxicol: Offic J Amer Acad Clin Toxicol & Eur Assoc Poisons Centr & Clin Toxicolo 2009; 47: 81-88.
43. Sheikh A, Alves B,. Hospital admissions for acute anaphylaxis: time trend study. BMJ 2000; 320: 1441.
44. van Puijenbroek EP, Egberts ACG, Meyboom RHB, Leufkens HGM,. Different risks for NSAID-induced anaphylaxis. Ann Pharmacother 2002; 36: 24-29.
45. Vetander M, Helander D, Flodstrom C, Ostblom E, Alfven T, Ly DH, et al. Anaphylaxis and reactions to foods in children-a population-based case study of emergency department visits. Clin Exp Allergy 2012; 42: 568-577.
46. Worm M, Edenharter G, Rueff F, Scherer K, Pfohler C, Mahler V, et al. Symptom profile and risk factors of anaphylaxis in central Europe. Allergy 2012; 67: 691-698.
47. Ayala F, Fabbrocini G, Bartiromo F, Barberio E, Rescigno O, Di Simone L, et al. Adverse drug reactions: dermatological experience. G Ital di Dermatol Venereol 2006; 141: 17-20.
48. Dietrich W, Ebell A, Busley R, Boulesteix A,. Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery. Ann Thorac Surg 2007; 84: 1144-1150.
49. Gibbison B, Sheikh A, McShane P, Haddow C, Soar J,. Anaphylaxis admissions to UK critical care units between 2005 and 2009. Anaesthesia 2012; 67: 833-838.
50. Gupta R, Sheikh A, Strachan D, Anderson HR,. Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions data. BMJ 2003; 327: 1142-1143.
51. Gupta R, Sheikh A, Strachan DP, Anderson HR,. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004; 34: 520-526.
52. Hopf Y, Watson M, Williams D,. Adverse-drug-reaction related admissions to a hospital in Scotland. Pharm World Sci 2008; 30: 854-862.
53. Mertes PM, Laxenaire M, Alla F,. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99: 536-545.
54. Mertes PM, Alla F, Trechot P, Auroy Y, Jougla E,. Groupe d'Etudes des Reactions Anaphylactoides, Peranesthesiques. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy & Clin Immunol 2011; 128: 366-373.
55. Sheikh A, Alves B,. Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clin Exp Allergy 2001; 31: 1571-1576.
56. Sheikh A, Hippisley-Cox JJ, Newton J, Fenty J,. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med 2008; 101: 139-143.
57. Tejedor Alonso MA, Moro Moro M, Mugica Garcia MV, Esteban Hernandez J, Rosado Ingelmo A, Vila Albelda C, et al. Incidence of anaphylaxis in the city of Alcorcon (Spain): a population-based study. Clin Exp Allergy 2012; 42: 578-589.
58. Tejedor Alonso MA, Moro MM, Hernandez JE, Mugica Garcia MV, Albelda CV, Ingelmo AR, et al. Incidence of anaphylaxis in hospitalized patients. Int Arch Allergy Immunol. 2011; 156: 212-220.
59. Pakravan N, Waring WS, Sharma S, Ludlam C, Megson I, Bateman DN,. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Clin Toxicol: Offic J Amer Acad Clin Toxicol & Eur Assoc Poisons Cent & Clin Toxicolo 2008; 46: 697-702.
60. Waring WS, Stephen AF, Robinson OD, Dow MA, Pettie JM,. Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose. Clin Toxicol 2008; 46: 496-500.
61. Moneret-Vautrin DA, Kanny G, Parisot L,. Serious food allergy-related accidents in France: frequency, clinical and etiological characteristics. First enquiry carried out by the French 'allergovigilance network'. [French] Accidents graves par allergie alimentaire en france: frequence, caracteristiques cliniques et etiologiques. Premiere enquete du reseau d'allergovigilance, avril-mai 2001. Revue Francaise d'Allergologie et d'Immunologie Clinique 2001; 41: 696-700.
62. Michalska-Krzanowska G, Kurek M, Ratajski R,. The incidence of anaphylactic reactions in 3560 patients undergoing TIVA with propofol, fentanyl and different neuromuscular blocking agents: a one-year retrospective study. Anestezjologia Intensywna Terapia 2006; 38: 125-128.
63. Mulier S, Hanssens L, Chaouat P, Casimir G,. [Child food allergy: Results of a Belgian cohort]. [French] L'allergie alimentaire chez l'enfant: etude d'une cohorte belge. Rev Med Brux 2006; 27 Spec No:Sp 82-86.
64. Rymarczyk B, Gluck J, Jozwiak P, Rogala B,. Incidence and variety of clinical manifestation of food hypersensitivity in the population of Silesia-A questionnaire based study. [Polish]Czestosc wystepowania i charakterystyka reakcji nadwrazliwosci na pokarmy w populacji Slaskiej-Badanie ankietowe. Alergia Astma Immunol 2009; 14: 248-251.
65. Couto M, de Almeida MM,. Allergic disease diagnosis in Portugal: an exploratory study. Diagnostico da doenca alergica em Portugal: um estudo exploratorio. Revista Portuguesa de Imunoalergol 2011; 19: 23-32.
66. Branellec A, Thomas M, Fain O, Kettaneh A, Stirnemann J, Letellier E,. Frequency of self-reported penicillin allergy in the area of Seine-Saint-Denis(France). Rev Med Interne 2008; 29: 271-276.
67. Lynch RM, Robertson R,. Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study. Accid Emerg Nurs 2004; 12: 10-15.
68. Cetinkaya F, Incioglu A, Birinci S, Karaman BE, Dokucu AI, Sheikh A,. Hospital admissions for anaphylaxis in Istanbul. Turkey. Allergy 2013; 68: 128-130.
69. Worm M,. Epidemiology of anaphylaxis., Ring J, (ed): Anaphylaxis. Chem Immunol Allergy. Basel, Karger, 2010, vol 95, pp 12-21.
70. Worm M, Hompes S, Vogel N, Kirschbaum J, Zuberbier T,. Care of anaphylaxis among practising doctors. Allergy 2008; 63: 1562-1563.
71. Akeson N, Worth A, Sheikh A,. The psychosocial impact of anaphylaxis on young people and their parents. Clin Exp Allergy 2007; 37: 1213-1220.
72. Anandan C, Simpson CR, Fischbacher C, Sheikh A,. Exploiting the potential of routine data to better understand the disease burden posed by allergic disorders. Clin Exp Allergy 2006; 36: 866-871.
73. Clark S, Camargo CA,. Epidemiology of anaphylaxis. Immunol Allergy Clin N Am 2007; 27: 145-163.